ENTITY

Nexalin Technology (NXL US)

3
Analysis
Health Care • United States
Nexalin Technology, Inc. operates as a medical device company. The Company designs and develops an easy-to-administer medical device that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Nexalin Technology serves customers worldwide.
more
Exchange Announcement • 09 Oct 2026 05:01

S-1/A | IPO Registration (Amendment)

Exchange Announcement • 02 Oct 2026 05:00

Current Report (Form 8-K | Period ending 2026-09-30)

Exchange Announcement • 02 Oct 2026 05:00

Current Report (Form 8-K | Period ending 2026-09-28)

Exchange Announcement • 29 Sep 2026 05:15

Current Report (Form 8-K | Period ending 2026-09-25)

Exchange Announcement • 23 Sep 2026 04:50

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

x